Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Lithium, particularly in its prescription form (lithium carbonate), is well-established in psychiatry for the treatment of bipolar disorder and has notable effects on the dopaminergic system of the brain. Scientific studies have demonstrated that lithium can modulate dopamine neurotransmission, primarily by decreasing dopamine receptor sensitivity and inhibiting dopamine release. This effect is thought to contribute to its mood-stabilizing properties, especially in reducing mania, which is associated with heightened dopaminergic activity. While these findings show that lithium interacts with the dopamine system, it is not typically used as a supplement specifically to "support" the dopamine system in healthy individuals but rather to reduce abnormal dopamine-driven activity in psychiatric conditions. The majority of evidence pertains to clinical doses of prescription lithium, not low-dose or supplement forms (such as lithium orotate), and there is limited high-quality research supporting the use of such supplements for dopamine-related support in the general population. Therefore, while there is clear scientific evidence for lithium's action on the dopamine system in the context of psychiatric treatment, the evidence for its use as a general dopamine system "support" is moderate and condition-specific rather than universally applicable.

More about Lithium
More about Dopamine

Other ingredients that support Dopamine

Other body systems supported by Lithium

Products containing Lithium